Literature DB >> 21818688

The pattern of cortical atrophy in Parkinson's disease with mild cognitive impairment according to the timing of cognitive dysfunction.

Ji E Lee1, Kyoo H Cho, Myonghwan Kim, Young H Sohn, Phil Hyu Lee.   

Abstract

The density of Lewy bodies or the concurrent β-amyloid pathology would act as modulators in the relative timing of dementia during the course of Parkinson's disease. Depending on the temporal relationship between the onset of parkinsonism and that of cognitive impairment, patients with Parkinson's disease with mild cognitive impairment were divided into two groups of earlier (<1 year) and later (≥1 year) cognitive decline, and cortical atrophy patterns and correlation of gray matter and timing of cognitive decline were analyzed using voxel-based morphometry. The morphometric analysis showed that patients with earlier cognitive decline demonstrated greater cortical atrophy in the inferior parietal and orbitofrontal areas than did those with later cognitive decline. Additionally, the anatomical bases of the timing of their cognitive decline differed in terms of correlation patterns. These data suggest that the pathological burden in Parkinson's disease with mild cognitive impairment may be more severe in patients with earlier cognitive decline than in those with later cognitive decline, and that the neural basis corresponding to the timing of cognitive decline may differ in these patients.

Entities:  

Mesh:

Year:  2011        PMID: 21818688     DOI: 10.1007/s00415-011-6203-x

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  20 in total

1.  Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease.

Authors:  H I Hurtig; J Q Trojanowski; J Galvin; D Ewbank; M L Schmidt; V M Lee; C M Clark; G Glosser; M B Stern; S M Gollomp; S E Arnold
Journal:  Neurology       Date:  2000-05-23       Impact factor: 9.910

2.  Neuropathology in Parkinson's disease with mild cognitive impairment.

Authors:  Kurt A Jellinger
Journal:  Acta Neuropathol       Date:  2010-10-05       Impact factor: 17.088

3.  CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: the Norwegian ParkWest study.

Authors:  Guido Alves; Kolbjørn Brønnick; Dag Aarsland; Kaj Blennow; Henrik Zetterberg; Clive Ballard; Martin Wilhelm Kurz; Ulf Andreasson; Ole-Bjørn Tysnes; Jan Petter Larsen; Ezra Mulugeta
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-06-14       Impact factor: 10.154

4.  A voxel-based morphometric study of ageing in 465 normal adult human brains.

Authors:  C D Good; I S Johnsrude; J Ashburner; R N Henson; K J Friston; R S Frackowiak
Journal:  Neuroimage       Date:  2001-07       Impact factor: 6.556

5.  Neuroanatomic basis of amnestic MCI differs in patients with and without Parkinson disease.

Authors:  J E Lee; H-J Park; S K Song; Y H Sohn; J D Lee; P H Lee
Journal:  Neurology       Date:  2010-11-30       Impact factor: 9.910

6.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

7.  A comparison of gray and white matter density in patients with Parkinson's disease dementia and dementia with Lewy bodies using voxel-based morphometry.

Authors:  Ji E Lee; Bosuk Park; Sook K Song; Young H Sohn; Hae-Jeong Park; Phil Hyu Lee
Journal:  Mov Disord       Date:  2010-01-15       Impact factor: 10.338

8.  Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.

Authors:  D Aarsland; K Brønnick; J P Larsen; O B Tysnes; G Alves
Journal:  Neurology       Date:  2008-11-19       Impact factor: 9.910

9.  Imaging beta-amyloid burden in aging and dementia.

Authors:  C C Rowe; S Ng; U Ackermann; S J Gong; K Pike; G Savage; T F Cowie; K L Dickinson; P Maruff; D Darby; C Smith; M Woodward; J Merory; H Tochon-Danguy; G O'Keefe; W E Klunk; C A Mathis; J C Price; C L Masters; V L Villemagne
Journal:  Neurology       Date:  2007-05-15       Impact factor: 9.910

10.  Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseases.

Authors:  Igor F Tsigelny; Leslie Crews; Paula Desplats; Gideon M Shaked; Yuriy Sharikov; Hideya Mizuno; Brian Spencer; Edward Rockenstein; Margarita Trejo; Oleksandr Platoshyn; Jason X-J Yuan; Eliezer Masliah
Journal:  PLoS One       Date:  2008-09-04       Impact factor: 3.240

View more
  3 in total

1.  Progression of brain atrophy in the early stages of Parkinson's disease: a longitudinal tensor-based morphometry study in de novo patients without cognitive impairment.

Authors:  Carlo Tessa; Claudio Lucetti; Marco Giannelli; Stefano Diciotti; Michele Poletti; Sabrina Danti; Filippo Baldacci; Claudio Vignali; Ubaldo Bonuccelli; Mario Mascalchi; Nicola Toschi
Journal:  Hum Brain Mapp       Date:  2014-01-22       Impact factor: 5.038

Review 2.  Dementia and neuroimaging.

Authors:  Federica Agosta; Francesca Caso; Massimo Filippi
Journal:  J Neurol       Date:  2012-12-15       Impact factor: 4.849

Review 3.  Neural and behavioral substrates of subtypes of Parkinson's disease.

Authors:  Ahmed A Moustafa; Michele Poletti
Journal:  Front Syst Neurosci       Date:  2013-12-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.